Kathryn Rudo
Dermatology · Westminster, MDNPI 1700981701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $257 and has fallen 60.4% since, to $102 in 2025. That places this record below the midpoint for dermatology clinicians in MD, where the typical reported total is $2,310.
Across 44 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$179
- Sanofi$92
- Novartis$76
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$64
- UCB, Inc.$63
- Hill Dermaceuticals, Inc.$41
- plus $338 from 15 others
What the payments were for
- Food & beverage$852100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $179 |
| Sanofi | 4 | $92 |
| Novartis | 4 | $76 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $64 |
| UCB, Inc. | 3 | $63 |
| Hill Dermaceuticals, Inc. | 2 | $41 |
| Johnson & Johnson | 2 | $38 |
| Strata Skin Sciences, Inc. | 4 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Pfizer | 2 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Amgen | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Dermira, Inc. | 1 | $16 |
| Glenmark Therapeutics Inc. | 1 | $14 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Dermavant Sciences, Inc. | 1 | $13 |
| Merck | 1 | $11 |
| Organon | 1 | $9 |
How this compares
$852 in reported general payments places this provider in the 35th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tretinoin | 33 | $3,038 |
| Fluorouracil | 20 | $1,245 |
| Metronidazole | 23 | $1,214 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 40 | $801 |
| Doxycycline Monohydrate | 35 | $784 |
| Ketoconazole | 26 | $604 |
| Clobetasol Propionate | 16 | $478 |
| Ciclopirox | 21 | $389 |
| Triamcinolone Acetonide | 55 | $358 |
| Mupirocin | 36 | $316 |
| Econazole Nitrate | 12 | $267 |
| Cephalexin | 30 | $176 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Westminster
- Benjamin LockshinSilver Spring$4M
- Shawn KwatraBaltimore$1.1M
- Chesahna Kindred WeaverMarriottsville$837K
- Oanh LauringNottingham$763K
- Ronald PrussickN Bethesda$620K
- Rebecca KazinChevy Chase$342K
- Susan WalkerBethesda$221K
- Monte MeltzerBerlin$220K
- Valerie CallenderGlenn Dale$183K
- David StrobelCatonsville$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.